About EUDA Health Holdings Limited
https://euda.comEUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
CEO
Alfred Lim
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public N/A
Method of going public SPAC
Full time employees 117
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $3.69 M
52w High $0.10
52w Low $0.07
P/E 0
Volume 12.00K
Outstanding Shares 36.86M
About EUDA Health Holdings Limited
https://euda.comEUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $1.53M | $983.75K | $-602K | -39.38% | $-0.02 | $-519.32K |
| Q1-2025 | $1.53M ▲ | $983.75K ▲ | $-602K ▼ | -39.38% ▼ | $-0.02 ▼ | $-519.32K ▼ |
| Q4-2024 | $1.05M | $655.1K | $735.34K | 69.93% | $-0.01 ▲ | $-476.94K |
| Q3-2024 | $1.05M ▲ | $655.1K ▼ | $735.34K ▲ | 69.93% ▲ | $-0.01 ▲ | $-476.94K ▲ |
| Q2-2024 | $954.02K | $8.39M | $-8.41M | -881.95% | $-0.29 | $-789K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $176.58K | $2.12M | $5.85M | $-3.71M |
| Q1-2025 | $176.58K ▼ | $2.12M ▲ | $5.85M ▲ | $-3.71M ▼ |
| Q4-2024 | $237.6K | $1.7M ▲ | $4.27M ▲ | $-2.55M ▲ |
| Q3-2024 | $237.6K ▼ | $1.7M ▼ | $4.27M ▼ | $-2.55M ▲ |
| Q2-2024 | $376.21K | $2.03M | $8.04M | $-6.02M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-602K | $-607.71K | $-11.61K | $558.88K | $0 | $-619.32K |
| Q1-2025 | $-602K ▼ | $-607.71K ▼ | $-11.61K ▲ | $558.88K ▲ | $0 | $-619.32K ▼ |
| Q4-2024 | $735.34K | $-388.06K | $-71.87K | $413.34K | $0 ▲ | $-435.87K |
| Q3-2024 | $735.34K ▲ | $-388.06K ▲ | $-71.87K ▼ | $413.34K ▼ | $-390.58K ▼ | $-435.87K ▲ |
| Q2-2024 | $-8.41M | $-629.3K | $-2.01K | $748.76K | $390.58K | $-629.88K |
Revenue by Products
| Product | Q1-2023 |
|---|---|
 Medical Services | $0 ▲ |
 Property Management Services | $0 ▲ |
CEO
Alfred Lim
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public N/A
Method of going public SPAC
Full time employees 117
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0